RT @DreJoanneLiu@twitter.com
Measles is ‘imminent threat’ globally, WHO and CDC warn. They said 25 million children did not receive their first dose, while an additional 14.7 million children missed their second shot, marking a record high in missed vaccinations. https://www.washingtonpost.com/health/2022/11/24/measles-threat-vaccine-who-cdc/
🐦🔗: https://twitter.com/DreJoanneLiu/status/1595962091911139329
We also have a large number of fully funded PhD studentships available at the moment. Come join our incredible community of researchers and contribute to world-leading research in microbiology and structural biology. Please direct enquiries to the individual members of staff
#introduction: I am a cognitive neuroscientist at the Ernst Strüngmann Institute in Frankfurt, Germany. I like structure and beauty and somehow that draws me to #oscillations in the brain, mainly recorded with #electrophysiology.
when I have time, I like to make animations of concepts related to that: http://mnemai.org/demos
maybe starting on a new platform will allow for more playfulness again, which I enjoyed at lot in the beginning on twitter. 🙂
RT @EvoBiomech
We are looking for an enthusiastic, curious & kind PhD candidate to join our team to work on foraging biomechanics in leaf-cutter ants in spring/fall 23. Fully funded (4y), with lots of freedom/possibility to contribute your own ideas. Details:
https://evo-biomech.ic.ac.uk/wp-content/uploads/Advert-1.pdf
Please RT!
RT @NCIResearchCtr@twitter.com
✒️#APPLYNOW The @theNCI@twitter.com is seeking an outstanding, internationally recognized, and visionary clinician-scientist to lead CCR's @nciccr_gmb@twitter.com https://ccr.cancer.gov/genitourinary-malignancies-branch! #ProstateCancer #KidneyCancer #BladderCancer
Learn more about this #CareerOpportunity here https://ccr.cancer.gov/careers/chief-genitourinary-malignancies-branch/25604
🐦🔗: https://twitter.com/NCIResearchCtr/status/1595490372616130585
Hi, all! I'm a professor at U Oregon, and I love evolution and ecology, population genetics and genoimc data, spatial data and spatial processes, and using simulation to learn stuff. I also spend a bunch of time teaching statistics.
I'm aiming to do a little social media break, but we'll see what happens!
COVID-19 is robbing Latino community of a secret weapon behind their success: grandparents
https://www.latimes.com/politics/story/2022-11-23/covid-19-struck-at-the-heart-of-latino-family-networks
RT @LabWalz
We are very excited to share our work published in @iscience showing that increased soluble HLA in COVID-19 present a disease-related diverse #immunopeptidome. Great work of our lab member @AnnikaNel.
https://www.cell.com/iscience/fulltext/S2589-0042(22)01915-0
I’m remembering that @stephenfry was a bright beacon in my earliest Twitter experience. How lovely to see him here now. https://mastodonapp.uk/@stephenfry/109399367443448303
How to stop Killers from turning on each other?
Engineering CAR-NK cells with ‘don’t kill me’ ligands circumvents problem of trogocytosis-mediated fratricide.
@brembs @minimammoth I can't speak for all publications, but Nature does pay journalists for the front matter content - these are commissioned pieces with a rate attached. So that actually is a legitimate cost (if you consider the content valuable). But it absolutely does not have to be packaged with the original research papers. I think this is a holdover from when they (the two weeklies) had a broader individual subscription base of people who read them as magazines.
@minimammoth Thank you - and I hope to have more convos here. Cheers
@minimammoth Yes, and now they often belong to ever larger conglomerates (and I suppose ultimately to the Scheinhardt wig company)
@minimammoth The only other scientific journal where for the last almost 30 years I've consistently read the front matter is Current Biology. (and back matter, the last page with Sidney Brenner was a reason to wait for the next issue at my university library)
@minimammoth Definitely is the case now - but I do remember a time when individual subscriptions (I had one) the Science and Nature were not uncommon, and they were read as magazines for the weekly news, book reviews, interviews etc and then you read the papers that caught your eye or were in your field. That could still work, I think - but with OA and preprints, that means enough subscribers for the news and front matter. I don't know if the numbers could work, but they might
@minimammoth The niche they fill in this respect is science journalism for a scientifically literate readership - so it's not like SciAm or the (again great) work of people like Carl Zimmer or Ed Yong. The economics of all this is a mess, but it was less complicated before commercial publishers began the brand driven expansion phase
@minimammoth sorry - one pandemic, one epidemic.
I've worked on all of science, from B cells to T cells.
https://fellowsherpa.com